Lataa...
AMP-independent activator of AMPK for treatment of mitochondrial disorders
Mitochondrial diseases are a clinically heterogenous group of disorders caused by respiratory chain dysfunction and associated with progressive, multi-systemic phenotype. There is no effective treatment or cure, and no FDA-approved drug for treating mitochondrial disease. To identify and characteriz...
Tallennettuna:
| Julkaisussa: | PLoS One |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7556449/ https://ncbi.nlm.nih.gov/pubmed/33052980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0240517 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|